Filing Details
- Accession Number:
- 0001127602-11-003912
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-04 16:31:56
- Reporting Period:
- 2011-02-02
- Filing Date:
- 2011-02-04
- Accepted Time:
- 2011-02-04 16:31:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1277495 | Carsten Boess | C/O Insulet Corporation 9 Oak Park Drive Bedford MA 01730 | Vice President, International | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-02 | 7,072 | $6.83 | 17,072 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-02-02 | 24,741 | $8.04 | 41,813 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-02 | 31,813 | $17.51 | 10,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-02-02 | 7,072 | $0.00 | 7,072 | $6.83 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-02-02 | 24,741 | $0.00 | 24,741 | $8.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,500 | 2019-02-26 | No | 4 | M | Direct | |
| 150,259 | 2016-06-01 | No | 4 | M | Direct |
Footnotes
- This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
- This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal monthly installments each month thereafter for 36 months, subject to continued employment.
- The price reported represents the weighed average sale price of the shares sold. The shares were sold at varying prices in the range of $17.50 to $17.60. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full informaiton regarding the number of shares sold at each separate price.
- Includes 10,000 restricted stock units granted on March 1, 2010 which vest one-third of the total units of the first anniversary date of the grant and one-third each on the second and third anniversaries of the date of the grant. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2010.
Billionaire Hedge Funds
